NASDAQ Stock Movers on FDA Decision (MITI, MYRX, ATHX, ICFI)

Micromet Inc. (NASDAQ:MITI) fell 0.75% to $6.62 on heavy volume after it announced that they have initiated a Phase 2 of MT103 (blinatumomab). The trial will be conducted in patients with elapsed or refractory B-precursor acute lymphoblastic leukemia (ALL).

You can Subscribe to these Free Stock Alerts by visiting:  http://www.PennyStockPickReport.com

This phase 2, single-arm study is intended to evaluate the efficacy, safety and tolerability of blinatumomab in 20 adult patients with B-precursor ALL who are resistant or intolerant to standard chemotherapy.

Myrexis, Inc. (NASDAQ:MYRX) rose 2.36% to $3.91 on heavy volume after it announces the presentation of key findings from MPC-9528 preclinical studies. The findings, which demonstrated significant tumor reduction, were: MPC-9528 is a potent and selective inhibitor; Co-administration of niacin (vitamin B3) improves MPC-9528's therapeutic index; Expression of Naprt1 is deficient in approximately 40% of all cancers; MPC-9528 causes dramatic tumor regressions across multiple tumor types.

Athersys, Inc. (NASDAQ:ATHX) rose 2..67% to $3.33 after the company  announces publication of a key study of an intravenous injection of MultiStem providing neurovascular protection after traumatic brain injury (TBI) in an established preclinical model of brain injury.

You can Subscribe to these Free Stock Alerts by visiting:  http://www.PennyStockPickReport.com

Athersys, Inc. is a biopharmaceutical company engaged in the discovery and development of therapeutic product candidates designed to extend and improve the quality of human life.

ICF International, Inc. (NASDAQ:ICFI) rose 0.04% to $23.05 after it announced that they have been awarded a $31.8 million re-compete contract from the U.S. FDA. The six-year contract was made to provide information technology (IT) and scientific support services to the National Center for Toxicological Research (NCTR).

ICF will provide the NCTR center in Jefferson, Ark., with computational science/bioinformatics support; development, enhancement, conversion, and maintenance of application systems; systems support; statistical support; customer support; and experiment support for specific toxicology studies.

About http://www.PennyStockPickReport.com

Penny Stock Pick Report offers stock newsletter on OTC, PINKSHEETS ,OTCBB, AMEX, NASDAQ and NYSE stock exchange. Our subscribers receive daily up to date stock information on hot stocks, most active movers, top gainers, penny stocks and much more. If you wish to feature your organization on our website then you can contact us at the email given below.